Rna Diagnostics Inc.
Rna Diagnostics solves a high priority problem in cancer treatment with the first real time chemotherapy guidance tool.
Rna Diagnostics has developed real-time cancer chemotherapy guidance tools. The RNA Disruption Assay (RDA™) is the only diagnostic tool that predicts early in treatment how a patient will respond to chemotherapy. Reduction of unnecessary chemotherapy is a top priority for breast oncologists. RDA™ improves patient outcomes while lowering breast cancer treatment cost.